Generic Pharmaceutical Company Pays $25 Million To Resolve False Claims Act Liability For Price-Fixing Of Generic Drugs

Generic Pharmaceutical Company Pays $25 Million To Resolve False Claims Act Liability For Price-Fixing Of Generic Drugs

Settlement Brings Total Recovered from Generic Pharmaceutical Companies to Over $500 Million in Civil Settlements and Over $1 Billion with Criminal Payments

PHILADELPHIA - U.S. Attorney Jacqueline C. Romero announced that Teva Pharmaceuticals USA, Inc., a generic pharmaceutical manufacturer located in Parsippany, New Jersey, has agreed to pay $25 million to resolve its alleged liability under the False Claims Act for conspiring to fix prices and allocate markets for two generic drugs. This settlement is one part of an overall resolution, for a total payment of $450 million, based on Teva's ability to pay, of allegations of this and another kickback arrangement.

Read more on www.justice.gov

Share